Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.09 USD
−4.20 M USD
31.79 M USD
14.59 M
About BRAINSWAY
Sector
Industry
CEO
Hadar Levy
Website
Headquarters
Jerusalem
Founded
2006
FIGI
BBG00N2K3XL3
Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.